tiprankstipranks
Genetic Technologies (GNTLF)
OTHER OTC:GNTLF
Holding GNTLF?
Track your performance easily

Genetic Technologies (GNTLF) Stock Price & Analysis

1 Followers

GNTLF Stock Chart & Stats


Financials

Annual

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

GNTLF FAQ

What was Genetic Technologies’s price range in the past 12 months?
Genetic Technologies lowest stock price was $0.00 and its highest was $1.00 in the past 12 months.
    What is Genetic Technologies’s market cap?
    Currently, no data Available
    When is Genetic Technologies’s upcoming earnings report date?
    Genetic Technologies’s upcoming earnings report date is Feb 26, 2025 which is in 65 days.
      How were Genetic Technologies’s earnings last quarter?
      Genetic Technologies released its earnings results on Aug 29, 2024. The company reported -$0.026 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.026.
        Is Genetic Technologies overvalued?
        According to Wall Street analysts Genetic Technologies’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Genetic Technologies pay dividends?
          Genetic Technologies does not currently pay dividends.
          What is Genetic Technologies’s EPS estimate?
          Genetic Technologies’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Genetic Technologies have?
          Currently, no data Available
          What happened to Genetic Technologies’s price movement after its last earnings report?
          Genetic Technologies reported an EPS of -$0.026 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
            Which hedge fund is a major shareholder of Genetic Technologies?
            Currently, no hedge funds are holding shares in GNTLF
            ---

            Genetic Technologies Stock Smart Score

            10
            Unlock Smart Score
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            20 days / 200 days
            Momentum
            -67.13%
            12-Months-Change

            Fundamentals

            Return on Equity
            -181.97%
            Trailing 12-Months
            Asset Growth
            -58.22%
            Trailing 12-Months

            Company Description

            Genetic Technologies

            Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Northwest Biotherapeutics
            Oncolytics Biotech
            CytoDyn
            BioNano Genomics
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis